Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.42548 | 16 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.40132 | 16 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.41094 | 17 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.70866 | 79 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.34785 | 16 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.4331 | 15 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.44024 | 17 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.39363 | 17 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.3899 | 17 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.38925 | 16 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.38173 | 16 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.44934 | 20 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.40195 | 17 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.38984 | 16 |